[Federal Register Volume 86, Number 67 (Friday, April 9, 2021)]
[Notices]
[Page 18534]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-07337]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Docket No. CDC-2021-0039]


Draft Recommendations for Prevention and Control of Infections in 
Neonatal Intensive Care Unit Patients: Central Line-Associated Blood 
Stream Infections (CLABSI)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (DHHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), in the 
Department of Health and Human Services (DHHS), announces the opening 
of a docket to obtain comment on the Draft Recommendations for 
Prevention and Control of Infections in Neonatal Intensive Care Unit 
Patients: Central Line-associated Blood Stream Infections (CLABSI). 
(``Draft Guideline''). The Draft Guideline provides new, evidence-based 
recommendations specific to the prevention and control of central line-
associated blood stream infections (CLABSI) in neonatal intensive care 
unit (NICU) patients.

DATES: Written comments must be received on or before June 8, 2021.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2021-
0039, by any of the following methods:
     Federal eRulemaking Portal: http://www.regulations.gov. 
Follow the instructions for submitting comments.
     Mail: Division of Healthcare Quality Promotion, National 
Center for Emerging and Zoonotic Infectious Diseases, Centers for 
Disease Control and Prevention, Attn: Docket No. CDC-2021-0039, HICPAC 
Secretariat, 1600 Clifton Rd. NE, Mailstop H16-2, Atlanta, Georgia, 
30329.
    Instructions: All submissions received must include the agency name 
and Docket Number. All relevant comments received will be posted 
without change to http://regulations.gov, including any personal 
information provided. For access to the docket to read background 
documents or comments received, go to http://www.regulations.gov.

FOR FURTHER INFORMATION CONTACT: Marwan Wassef, M.P.H., Division of 
Healthcare Quality Promotion, National Center for Emerging and Zoonotic 
Infectious Diseases, Centers for Disease Control and Prevention, 1600 
Clifton Road NE, Mailstop H16-2, Atlanta, Georgia, 30329; Email: 
[email protected]; Telephone: (404) 639-4000.

SUPPLEMENTARY INFORMATION:

Public Participation

    Interested persons or organizations are invited to participate by 
submitting written views, recommendations, and data related to the 
Draft Guideline.
    Please note that comments received, including attachments and other 
supporting materials, are part of the public record and are subject to 
public disclosure. Comments will be posted on https://www.regulations.gov. Therefore, do not include any information in your 
comment or supporting materials that you consider confidential or 
inappropriate for public disclosure. If you include your name, contact 
information, or other information that identifies you in the body of 
your comments, that information will be on public display. CDC will 
review all submissions and may choose to redact, or withhold, 
submissions containing private or proprietary information such as 
Social Security numbers, medical information, inappropriate language, 
or duplicate/near duplicate examples of a mass-mail campaign. CDC will 
carefully consider all comments submitted in preparation of the final 
Guideline for Prevention and Control of Infections in Neonatal 
Intensive Care Unit Patients and may revise the final document as 
appropriate.

Background

    The Draft Guideline, located in the ``Supporting & Related 
Material'' tab of the docket, provides new, evidence-based 
recommendations specific to the prevention and control of CLABSI in 
NICU patients, including insertion and maintenance practices.
    The Draft Guideline is intended for use by infection prevention 
staff, healthcare epidemiologists, healthcare administrators, nurses, 
neonatologists, other healthcare providers, and persons responsible for 
developing, implementing, and evaluating infection prevention and 
control programs for NICUs. The guideline can also serve as a resource 
for societies or organizations to develop more detailed implementation 
guidance for the prevention of infection in NICU patients.
    The Healthcare Infection Control Practices Advisory Committee 
(HICPAC), a federal advisory committee chartered to provide advice and 
guidance to the CDC, worked with national partners, academicians, 
public health professionals, healthcare providers, and other partners 
to develop this Draft Guideline. HICPAC includes representatives from 
public health, infectious diseases, regulatory and other federal 
agencies, professional societies, and other stakeholders.
    The draft recommendations in this Draft Guideline are informed by a 
systematic review of the best available literature through February 
2017 and of relevant references published since February 2017 suggested 
by subject matter experts. This Draft Guideline will not be a federal 
rule or regulation.

    Dated: April 6, 2021.
Sandra Cashman,
Executive Secretary, Centers for Disease Control and Prevention.
[FR Doc. 2021-07337 Filed 4-8-21; 8:45 am]
BILLING CODE 4163-18-P